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Abstract
Background: Diabetes is an important predictor of mortality patients with ACS. However, little
is known about the association between diabetes and health status after ACS. The objective of this
study was to examine the association between diabetes and patients' health status outcomes one
year after an acute coronary syndrome (ACS).
Methods: This was a prospective cohort study of patients hospitalized with ACS. Patients were
evaluated at baseline and one year with the Seattle Angina Questionnaire (SAQ). Socio-
demographic and clinical characteristics were ascertained during index ACS hospitalization. One
year SAQ Angina Frequency, Physical Limitation, and Health-Related Quality of Life (HRQoL)
scales were the primary outcomes of the study.
Results: Of 1199 patients, 326 (37%) had diabetes. Patients with diabetes were more likely to
present with unstable angina (52% vs. 40%; p < 0.001), less likely to present with STEMI (20% vs.
31%; p < 0.001), and less likely to undergo coronary angiography (68% vs. 82%; p < 0.001). In
multivariable analyses, the presence of diabetes was associated with significantly more angina (OR
1.36; 95% CI 1.01–1.38), cardiac-related physical limitation (OR 1.94; 95% CI 1.57–3.24) and
HRQoL deficits (OR 1.43; 95% CI 1.01–2.04) at one year.
Conclusion:  Diabetes is associated with more angina, worse physical limitation, and worse
HRQoL one year after an ACS. Future studies should assess whether health status outcomes of
patients with diabetes could be improved through more aggressive ACS treatment or post-
discharge surveillance and angina management.
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Background
Acute coronary syndromes (ACS), including unstable
angina, non-ST-elevation myocardial infarction
(NSTEMI) and ST-elevation myocardial infarction
(STEMI), affect approximately one million Americans
each year [1]. As improved therapies have resulted in
lower ACS mortality, patient health status has been
increasingly recognized as a critical outcome, with greater
emphasis being placed on the therapeutic goals of reduc-
ing symptoms, improving function, and optimizing
health related quality of life (HRQoL). In addition to
being an important patient-centered outcome, health sta-
tus predicts subsequent mortality and morbidity in car-
diac populations [2-4]. To date, few studies have
examined the factors associated with health status out-
comes following ACS.
Diabetes is an established and highly prevalent risk factor
for cardiac morbidity and mortality, and therefore is an
important comorbidity in patients with ischemic heart
disease (IHD). However, little is known about the associ-
ation between diabetes and health status outcomes after
ACS. It is important to assess the impact of diabetes on
health status outcomes in cardiovascular populations.
First, there is a general perception that patients with dia-
betes are less likely to experience angina than patients
without diabetes[5]. Yet, patients with diabetes often have
a high burden of coronary atherosclerosis[6], suggesting
increased potential for ischemic symptoms. To date, the
severity of angina following ACS in patients with diabetes
versus those without has not been described. Second,
although diabetes has been associated with worse overall
HRQoL in general populations [7,8], the impact of diabe-
tes on cardiac-specific health status after ACS compared to
traditional cardiac factors (e.g. ejection fraction) is not
known.
The goal of this study was to prospectively evaluate the
association between diabetes and cardiac-specific health
status (angina frequency, physical limitation and HRQoL)
in patients one year after an ACS, independent of other
known predictors. The results of this study are intended to
inform clinicians about the importance of diabetes as a
risk factor for health status outcomes after ACS, and
potentially lead to interventions to improve health status
outcomes in patients with diabetes.
Methods
Study population
The INvestigation oF Outcomes from acute coRonary syn-
droMes (INFORM) study was a prospective cohort study
designed to describe the health status of patients with
ACS, to determine predictors of health status at one year
following ACS, and to define the impact of ACS treatment
on patients' health status. Patients were enrolled from two
Kansas City, Missouri hospitals (Mid-America Heart Insti-
tute and Truman Medical Center) between March 1, 2001
and October 31, 2002. In total, 10,911 consecutive hospi-
talized patients who had a troponin blood test performed
were prospectively screened for a possible ACS. Standard
definitions were used to diagnose ACS patients with either
myocardial infarction (MI) or unstable angina. MI
patients were defined by a positive troponin blood test in
the setting of symptoms or electrocardiographic changes
(ST segment elevation, ST-segment depressions, or T-wave
inversions) consistent with an MI[9]. Unstable angina was
diagnosed if the patient had a negative troponin blood
test and any one of the following: new onset angina (< 2
months) of Canadian Cardiovascular Society Classifica-
tion class III or IV, prolonged (>20 minutes) rest angina,
recent (< 2 months) worsening of angina, or angina that
occurred within 2 weeks of an MI [10]. We excluded all
potential unstable angina patients who had a diagnostic
study (i.e. coronary angiography, nuclear or echocardio-
graphic stress testing) that excluded obstructive coronary
disease or who had an additional diagnostic study con-
firming an alternative explanation for the patients' presen-
tation. Among the 1606 eligible patients, 1199 (75%)
were enrolled. Among those who were eligible but not
enrolled, 70% were discharged or transferred prior to con-
tact, 25% refused, and 5% died prior to contact. The study
received Institutional Review Board approval at both par-
ticipating medical centers and all subjects signed
informed consent.
Each participating patient was prospectively interviewed
as early as possible during their index ACS admission to
ascertain their socio-demographic and baseline health sta-
tus characteristics. Detailed chart abstractions were per-
formed to ascertain patients' medical history, laboratory
results, disease severity and the processes of inpatient care.
The Social Security Administration Death Master File was
queried to determine patients' vital status in the year after
enrollment. Surviving patients were contacted by tele-
phone one year after ACS for a follow-up interview to
reassess their clinical and health status. A minimum of 12
attempts to contact patients were made, including con-
tacting up to 2 additional individuals designated by
patients at the time of their baseline interview as people
who would know their whereabouts.
Variables/measures
Disease-specific health status was measured at baseline
(during index ACS admission) and at one year post-ACS
by the Seattle Angina Questionnaire (SAQ). The SAQ is a
19-item disease-specific measure for patients with coro-
nary artery disease that has well-established validity,
reproducibility, sensitivity to clinical change, and prog-
nostic value[2,11,12]. The SAQ quantifies five clinically
relevant dimensions of coronary artery disease: physicalBMC Cardiovascular Disorders 2006, 6:41 http://www.biomedcentral.com/1471-2261/6/41
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limitation, anginal stability, angina frequency, treatment
satisfaction, and quality of life. The scales for these dimen-
sions range from 0–100, with higher scores indicating
fewer symptoms, better function, and better quality of life.
Conversely, lower SAQ scores reflect more frequent
angina, more severe physical limitation, and worse
HRQoL. One-year SAQ Angina Frequency, Physical Limi-
tation, and Quality of Life scales were the primary out-
comes for this study.
To accommodate skewed distributions of SAQ scores
(approximately 70% of patients had no angina symptoms
at one year), and to improve scale interpretability, the
SAQ angina frequency, physical limitation and HRQoL
scores were dichotomized into the presence or absence of
angina, presence or absence of cardiac-related physical
limitation and the presence or absence of HRQoL deficits,
respectively. The physical limitation section of the SAQ
asks patients to indicate if they were limited due to rea-
sons other than chest pain or angina. For analytic pur-
poses, patients whose limitations were due to non-cardiac
causes were given a score of 100 on the SAQ sub-scale
(indicating no cardiac-related physical limitation). A sen-
sitivity analysis was done excluding those indicated limi-
tations for non-cardiac related reasons, which did not
significantly alter the results. Furthermore, secondary
analyses were performed using the Physical Component
Summary (PCS) score from the SF-12 to evaluate the asso-
ciation between diabetes and overall physical health sta-
tus one-year after ACS.
Overall (generic) health status was evaluated using the
Short Form-12 (SF-12) health status survey. The SF-12 is
reliable and valid, consisting of 12 items that reflect over-
all physical and mental well-being (i.e. does not contain
disease-specific questions). Scoring for the PCS and Men-
tal Component Summary (MCS) scores of the SF-12 fol-
lowed the methods described by Ware et al[13]. The PCS
and MCS scores range from 0–100. Higher scores on the
PCS indicate fewer physical limitations, disabilities, or
decrements in well-being. For the MCS, higher scores indi-
cate frequent positive affect, less psychological distress
and less limitation in usual social/role activities due to
emotional problems. The one-year PCS and MCS scores
were secondary outcomes in this study.
The primary independent variable of interest for this study
was diabetes mellitus. Patients were considered to have
diabetes if it was recorded in the medical record or if they
were on diabetes medication at the time of ACS admis-
sion. A sensitivity analysis including the 44 patients newly
diagnosed with diabetes during their ACS hospitalization,
did not significantly alter the results. Additional variables
available for risk adjustment included the demographic,
cardiac factors, noncardiac factors, and treatment varia-
bles listed in Tables 1 and 2.
Statistical analysis
Statistical analyses were performed using SAS version 9.1
(SAS Institute, Cary, NC). Baseline characteristics of
patients with and without diabetes were compared using
t-tests for continuous variables and χ2 tests for categorical
variables. The unadjusted associations between diabetes
and primary cardiac-specific health status outcomes were
evaluated by comparing the proportion of patients with
any angina, any degree of physical limitation or any
HRQoL deficits between those with and without diabetes
using  χ2 tests. Secondary univariate analyses compared
mean SAQ scores for each subscale and mean PCS and
MCS scores one year following ACS between participants
with and without diabetes using t-tests.
Multivariable logistic regression was used to evaluate the
risk-adjusted association between diabetes and one-year
post-ACS health status. In addition, analyses using multi-
ple linear regression with SAQ scores as continuous out-
comes were performed to ensure that categorization did
not obscure any effects and yielded results similar to the
primary analyses. Finally, multivariable linear regression
was used to evaluate the association between diabetes and
overall mental health status as measured by MCS scores
from the SF-12.
Primary multivariable models were constructed using for-
ward selection on the candidate pool of independent var-
iables listed in Tables 1 and 2 (p < 0.10 to enter model and
p < 0.05 to be retained in model), forcing in diabetes and
baseline health status. For each model, the corresponding
baseline health status variable was included to adjust for
baseline differences in the outcome of interest. For exam-
ple, models of one-year angina frequency were adjusted
for baseline angina frequency. Secondary analyses were
performed including all Table 1 and 2 variables as covari-
ates in the models to maximize control of confounding.
Missing follow-up health status assessments can poten-
tially produce a selection bias from survey non-respond-
ers that influences the results of health status studies [14].
Several sources of missing data were present in this analy-
sis. First, 81 patients died within 12 months and thus did
not have one year health assessments performed. Patients
who died within 12 months were thereby excluded from
analyses and the results presented should be interpreted
as representative of those who survived for at least one
year after ACS. Second, response data at one-year was not
available for 199 patients because they could not be con-
tacted (n = 144) or refused to complete a one-year inter-
view (n = 55). There were no differences in the prevalence
of diabetes or in baseline health status among those whoBMC Cardiovascular Disorders 2006, 6:41 http://www.biomedcentral.com/1471-2261/6/41
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responded and those who were lost to follow-up at one
year. Furthermore, for those patients who refused one-
year interviews or could not be contacted, propensity
scores were computed using logistic regression analyses to
predict their likelihood of unsuccessful follow-up. From
these models, a probability of failure to complete an inter-
view was calculated. The reciprocal of this probability was
then assigned to those patients' scores in the multivariable
regression analyses models in order to appropriately
weight patient scores in the analysis to account for bias
due to loss to follow-up. These adjustments resulted in no
significant differences in effect sizes or statistical signifi-
cance for the association between diabetes and angina fre-
quency, physical limitation, or HRQoL compared to
primary analyses, and thus supported no significant bias
in the multivariable models.
Results
Of the 1,199 patients in the cohort, 326 patients (27%)
had diabetes. Baseline characteristics of patients with and
without diabetes are listed in Table 1. Compared to those
without diabetes, patients with diabetes were more likely
to be female, non-Caucasian and to have a history of MI,
CABG and heart failure. Hyperlipidemia, hypertension,
stroke, peripheral vascular disease, renal dysfunction and
chronic lung disease were also more common among
those with diabetes. There was no significant difference
among those with and without diabetes in left ventricular
function.
ACS characteristics and treatments are presented in Table
2. Patients with diabetes were more likely to present with
unstable angina (52% vs. 40%; p < 0.001) and less likely
to present with STEMI (20% vs. 31%; p < 0.001). Patients
with diabetes were less likely to have coronary angiogra-
phy performed during index ACS hospitalization (68% vs.
82%; p < 0.001). The proportion of participants with and
without diabetes receiving angiography was significantly
different among those with unstable angina (65% vs.
74%), but similar among those with NSTEMI (84% vs.
88%) and STEMI (95% vs. 96%). Among patients who
underwent coronary angiography, those with diabetes
were more likely to have 3-vessel coronary artery disease
(58% vs. 45%; p = 0.003). In the year following the index
ACS hospitalization, there was no significant difference
between those with and without diabetes in the number
of percutaneous interventions performed (16.5% vs. 20%;
p = 0.82). There was a trend toward more CABG proce-
dures (12% vs. 6%; p = 0.06) in patients with diabetes.
Table 1: Baseline characteristics among those with and without diabetes.
Variables Diabetes (n = 326) No Diabetes (n = 873) p-value
Demographic
Age, yrs (mean, SD) 62 (12) 61 (13) 0.58
Gender (% male) 51% 65% <0.001
Race (%)
Caucasian 72% 84% <0.001
African American 24% 13%
Hispanic 3% 2%
Other 1% 1%
Cardiac History
Heart failure (%) 14% 4% <0.001
Left ventricular ejection fraction (mean, SD) 47% (13) 47% (13) 0.82
Prior MI (%) 44% 28% <0.001
Prior PCI (%) 38% 33% 0.11
Prior CABG (%) 24% 17% 0.01
Family history of CAD (%) 59% 55% 0.21
Non-Cardiac History
Hypertension (%) 79% 61% <0.001
Hyperlipidemia (%) 46% 33% <0.001
History of smoking (%) 58% 70% <0.001
Alcohol or substance abuse (%) 5% 10% 0.003
Chronic Lung Disease (%) 14% 10% 0.03
Stroke (%) 4% 1% 0.002
PVD (%) 11% 4% <0.001
Renal Failure (%) 4% 1% 0.01
Admit Creatinine < 2.0 (%) 94% 98% <0.001
Arthritis (%) 16% 14% 0.60
CHF = congestive heart failure; MI = myocardial infarction; PCI = percutaneous intervention; CABG = coronary artery bypass graft surgery; CAD 
= coronary artery disease; PVD = peripheral vascular diseaseBMC Cardiovascular Disorders 2006, 6:41 http://www.biomedcentral.com/1471-2261/6/41
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At the time of the index hospitalization, patients with dia-
betes had lower mean SAQ scores for angina frequency
(72 vs 77; p = 0.001) and physical limitation (78 vs 87; p
< 0.001), but no significant difference in HRQoL scores
(49 vs 50; p = 0.25). One year following ACS, patients
with diabetes had significantly lower SAQ angina fre-
quency (85 vs. 91; p = 0.0006), physical limitation (82 vs.
92; p < 0.0001) and HRQoL (76 vs. 84; p < 0.0001) scores
compared to patients without diabetes.
In unadjusted analysis, patients with diabetes, when com-
pared to those without diabetes, were significantly more
likely to have angina of any degree (37% vs. 27%; p =
0.003), cardiac-related physical limitation (35% vs. 27%;
p < 0.001), and HRQoL deficits (53% versus 42%; p =
0.035, Figure 1) one year following ACS. Furthermore,
patients with diabetes had worse overall physical health
status (mean PCS scores 37 vs. 44; p < 0.0001), and men-
tal health status (mean MCS scores 52 vs. 55; p = 0.0013)
compared to patients without diabetes.
In multivariable analyses, diabetes remained significantly
associated with an increased presence of angina, cardiac-
related physical limitation and HRQoL deficits one year
after ACS. After adjustment for demographic, cardiac,
non-cardiac, and treatment variables, patients with diabe-
tes had significantly higher odds of having angina (OR
1.36; 95% CI 1.01–1.38), cardiac-related physical limita-
tion (OR 1.94; 95% CI 1.57–3.24) and HRQoL deficits
(OR 1.43; 95% CI 1.01–2.04) at one year compared to
patients without diabetes.
In multivariable models, additional predictors of having
angina were age (OR 1.08; 95% CI 1.00–1.15 per decade
decrement), history of MI (OR 1.60; 95% CI 1.21–2.13),
hypercholesterolemia (OR 0.75; 95% CI 0.57–0.98), his-
tory of alcohol or substance abuse (OR 2.0; 95% CI 1.20–
Unadjusted proportions of patients with and without diabe- tes with angina, cardiac-specific physical limitations and  HRQoL deficits as measured by the SAQ one year following  ACS Figure 1
Unadjusted proportions of patients with and without diabe-
tes with angina, cardiac-specific physical limitations and 
HRQoL deficits as measured by the SAQ one year following 
ACS.
0
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Table 2: ACS characteristics and treatment among those with and without diabetes.
Variable Diabetes (n = 326) No Diabetes (n = 873) p-value
ACS Characteristics
Type of ACS (%)
STEMI 20% 31% <0.001
NSTEMI 28% 29% 0.63
UA 52% 40% <0.001
3-Vessel Disease 58% 45% 0.003
Coronary Angiography 68% 82% <0.001
STEMI 95% 96%
NSTEMI 84% 88%
UA 65% 74%
Reperfusion (acute) (%)
PCI 18% 33% <0.001
Thrombolytics 5% 8% 0.02
Revascularization (%)
PCI 48% 62% <0.001
CABG 3% 4%
Medical Management 49% 35%
Discharge Treatment
Aspirin (%) 92% 95% 0.09
Beta-blocker (%) 79% 81% 0.41
ACE-I or ARB (%) 81% 74% 0.008
Statins (%) 75% 74% 0.94
ACS = acute coronary syndrome; STEMI = ST-elevation myocardial infarction; NSTEMI = non-ST-elevation myocardial infarction; UA = unstable 
angina; PCI = percutaneous intervention; CABG = coronary artery bypass graft surgery; ACE-I = angiotensin converting enzyme inhibitor; ARB = 
angiotensin receptor blockerBMC Cardiovascular Disorders 2006, 6:41 http://www.biomedcentral.com/1471-2261/6/41
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3.38), chronic lung disease (OR 2.74; 95% CI 1.76–4.26),
and history of peripheral vascular disease (OR 1.75; 95%
CI 1.02–3.02). Additional predictors of physical limita-
tion were female gender (OR 1.65; 95% CI 1.19–2.28),
Caucasian race (OR 0.61; 95% CI 0.40–0.93), history of
MI (OR 1.61; 95% CI 1.15–2.24), history of alcohol or
substance abuse (OR 2.28; 95% CI 1.27–4.09), discharge
prescription of an angiotensin converting enzyme inhibi-
tor or an angiotensin receptor blocker (OR 1.52; 95% CI
1.07–2.16) and chronic lung disease (OR 2.15; 95% CI
1.15–4.00). The additional predictors of HRQoL deficits
were age (OR 1.28; 95% CI 1.14–1.45 per decade decre-
ment), ejection fraction (OR 1.12 (1.01–1.27 per 10%
decrease), acute thrombolytic therapy (OR 1.92; 95% CI
1.01–3.66), and chronic lung disease (OR 2.36; 95% CI
1.33–4.20).
In multivariable linear regression analyses, diabetes
remained significantly associated with worse overall phys-
ical function as measured by the SF-12. PCS scores were,
on average, three points lower for those with diabetes
compared to those without diabetes (β = 2.85 +/- 1.12, p
= 0.01). Diabetes was not independently associated with
differences in MCS scores (β = 1.26 +/- 0.93, p = 0.18).
Discussion and conclusion
The goal of this study was to examine the association
between diabetes and patients' health status outcomes
one year after an ACS. We found that patients with ACS
and coexisting diabetes were more likely to present with
unstable angina, and were less likely to undergo coronary
angiography during ACS hospitalization. At one year fol-
lowing ACS, patients with diabetes were significantly
more likely to have angina, cardiac-related physical limi-
tation and HRQoL deficits compared to patients without
diabetes. These associations remained significant after
adjustment for a wide array of demographic, disease sever-
ity, comorbid condition, and treatment variables. Diabe-
tes was also negatively associated with overall physical
health status, but was not significantly associated with
overall mental health status.
It may be surprising that patients with diabetes were more
likely to have angina one-year post ACS. Previous studies
have shown that patients with diabetes have a higher rate
of silent myocardial ischemia [15-17], although this has
not been a consistent finding [18,19]. However, it is not
appropriate to conclude that diabetics with coronary
artery disease necessarily experience less angina. To our
knowledge, no previous study has directly evaluated the
angina burden of patients with diabetes after ACS. The
results of this study support that patients with diabetes are
more likely than non-diabetics to have angina one year
after ACS.
The results of this study support the potential for more
aggressive identification and treatment of angina in
patients with diabetes following ACS in order to improve
outcomes. Angina decreases patients' quality of life, is
associated with worse patient satisfaction, and increases
the risk for subsequent ACS and death[2,3,20-22]. There
are a range of therapies for angina, including pharmaco-
logic management, coronary revascularization, and other
interventions such as enhanced external counterpulsation
[23]. However, angina is often inadequately recognized
and treated in routine clinical practice, including under-
use and under-dosing of beta-blockers, long acting
nitrates, and calcium channel blockers [24-27]. Future
studies should assess whether the post-ACS outcomes of
patients with diabetes can be improved by employing
strategies to enhance post-discharge surveillance and
treatment of angina such as disease management or car-
diac rehabilitation. While evidence supports these inter-
ventions in general cardiac populations, [28,29] studies
have not specifically targeted patients with diabetes.
We also found that patients with diabetes and unstable
angina were less likely to receive coronary angiography,
raising the possibility that greater use of an early invasive
strategy in diabetic patients could improve outcomes. The
discrepancy in angiography rates did not appear to be
wholly or directly attributable to clinician concerns over
impaired renal function given that 94% of diabetic
patients had admission creatinine levels <2.0 μg/ml. Cur-
rent American Heart Association/American College of
Cardiology guidelines for ACS state that in the absence of
high-risk indicators such as new ST-segment depression,
symptoms of heart failure or high-risk findings on non-
invasive testing, an early conservative or  invasive
approach can be taken with similar morbidity and mortal-
ity outcomes [30]. Given the results of this study, in which
diabetics are more prone to persistent angina and dimin-
ished quality of life after an ACS, future clinical trials
should assess whether an early invasive approach in
patients with diabetes presenting with ACS, even in the
absence of other high-risk indicators, can improve health
status outcomes.
The results of this study expand the previous literature on
diabetes and health status in cardiac populations. Prior
studies have suggested that diabetes is associated with
greater overall physical limitation and worse quality of life
following CABG surgery or PCI [31,32]. Previous studies
on the association between diabetes and post-ACS health
status outcomes have been conflicting [33,34]. Impor-
tantly, studies to date have not included evaluation of car-
diac-specific health status, and the absence of baseline
measures of health status in most of these studies pre-
cluded the ability to adjust for baseline health status dif-
ferences. This study therefore adds to our knowledge byBMC Cardiovascular Disorders 2006, 6:41 http://www.biomedcentral.com/1471-2261/6/41
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prospectively evaluating the influence of diabetes on the
health status of patients with ACS, using both cardiac-spe-
cific and generic measures of health status in a large unse-
lected population of patients across the spectrum of ACS,
including adjustment for baseline health status.
Potential limitations to this study should be considered.
First, missing follow-up health status assessments can bias
quality of life studies [14]. However, there was no differ-
ence in the rate of missing surveys between patients with
and without diabetes. Furthermore, statistical methods to
assess for the impact of missing values did not suggest sig-
nificant bias in the multivariable models. Second, as an
observational study, residual unmeasured confounding
may be present. However, a wide range of measured vari-
ables were considered in multivariable regression models.
One potential confounder, severity of CAD, is difficult to
quantify in patients with diabetes, who are known to be at
risk for more diffuse CAD. In this study, severity of CAD
was adjusted for as possible using the combination of 1,
2, or 3-vessel coronary artery disease and left ventricular
ejection fraction. Finally, because the focus of the parent
study was ACS and not diabetes per se, details on diabetic
microvascular complications were not collected and could
not be specifically considered in multivariable models.
However, renal function, peripheral vascular disease and
baseline health status were included, which are likely to
reflect pre-existing diabetic complications influencing
health status.
In conclusion, we found that diabetes was associated with
more angina, greater cardiac-specific physical limitation,
and worse HRQoL one year after an ACS. Future studies
should evaluate interventions to reduce angina burden
and improve the health status of patients with diabetes
following ACS. Potential strategies include an early inva-
sive approach for unstable angina in patients with diabe-
tes and more aggressive surveillance and therapy for
angina in the post-ACS period. It is hoped that such inter-
ventions will optimize the patient-centered outcomes of
symptom burden, physical function, and quality of life for
the growing population of patients with diabetes and
CAD.
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